Atara Biotherapeutics (NASDAQ:ATRA) Lowered to “Sell” at StockNews.com
StockNews.com lowered shares of Atara Biotherapeutics (NASDAQ:ATRA – Free Report) from a hold rating to a sell rating in a report published on Monday. Atara Biotherapeutics Stock Performance NASDAQ:ATRA opened at $0.60 on Monday. The stock has a 50-day simple moving average of $0.74 and a two-hundred day simple moving average of $0.94. Atara Biotherapeutics […]
More Stories
Insider Selling: Meta Platforms, Inc. (NASDAQ:META) COO Sells 620 Shares of Stock
Meta Platforms, Inc. (NASDAQ:META – Get Free Report) COO Javier Olivan sold 620 shares of the firm’s stock in a...
Nature’s Miracle (NASDAQ:NMHI) Shares Scheduled to Reverse Split on Thursday, November 21st
Nature’s Miracle Holding Inc. (NASDAQ:NMHI – Free Report) shares are set to reverse split before the market opens on Thursday,...
Travis Perkins (OTCMKTS:TVPKF) Sets New 12-Month Low – Here’s Why
Travis Perkins plc (OTCMKTS:TVPKF – Get Free Report)’s stock price reached a new 52-week low on Tuesday . The stock...
Varex Imaging (NASDAQ:VREX) Updates Q1 2025 Earnings Guidance
Varex Imaging (NASDAQ:VREX – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Tuesday morning....
Datadog, Inc. (NASDAQ:DDOG) President Amit Agarwal Sells 150,000 Shares
Datadog, Inc. (NASDAQ:DDOG – Get Free Report) President Amit Agarwal sold 150,000 shares of the business’s stock in a transaction...
Cameco Co. (TSE:CCO) Senior Officer Sells C$1,124,678.76 in Stock
Cameco Co. (TSE:CCO – Get Free Report) (NYSE:CCJ) Senior Officer Brian Arthur Reilly sold 14,062 shares of the business’s stock...